Search Results for: US Stem Cell

STAP cell 2.0? New stem cell paper controversy ready to erupt

STAP2.0

Did you eventually get sick of the whole STAP mess and all the baggage that came with it? Stay tuned for STAP 2.0 or perhaps I should say STAP junior. Just as STAP is starting to fade a bit from our radar screens, there is unfortunately a new very problematic stem cell paper situation coming soon […]

STAP cell 2.0? New stem cell paper controversy ready to erupt Read More »

Harvard Predicts Fat Burning Stem Cell Pill To Replace Exercise

Moisan-et-al

A hot topic in biomedical sciences is converting white “bad” fat into brown “good” fat. The latter type of adipose is viewed more positively because it seems to be associated with a relatively metabolically more active, leaner state. Could we somehow convert white adipose to brown adipose and in so doing have a beneficial effect

Harvard Predicts Fat Burning Stem Cell Pill To Replace Exercise Read More »

STAP cells Voted as the Stem Cell Story of the Year for 2014

Stem-Cell-Story-of-2014

When I asked the readers of this blog what they felt was the biggest stem cell story of 2014 in a poll, they overwhelmingly picked the STAP cell scandal. For background on STAP you can toggle through the many STAP cell pieces on this blog here, see a STAP timeline, and a STAP image gallery. Basically,

STAP cells Voted as the Stem Cell Story of the Year for 2014 Read More »

Did NBC News Err On Key Part of Their Stem Cell Report?

Steven-Gitt-Nancy-Snyderman

NBC News did a big on-line story and even a NBC Nightly News Segment on dubious stem cell therapies on Friday. Normally a national news story on the problem of the mushrooming stem cell clinics selling unapproved “treatments” would be a positive development, but this otherwise very nicely done story might have a major error that could confuse millions

Did NBC News Err On Key Part of Their Stem Cell Report? Read More »

FDA on Key Stem Cell Regulatory Issues & Its Own Research

FDA3

It’s been a seemingly rather quiet year on the FDA regulatory front in the US when it comes to direct-to-consumer stem cell interventions even as the number of dubious stem cell clinics continues to skyrocket. I requested an interview with the FDA to cover the key pressing issues in this arena. I want to thank

FDA on Key Stem Cell Regulatory Issues & Its Own Research Read More »